Low-intensity Focused Ultrasound and Autonomic Response
NCT ID: NCT05834829
Last Updated: 2025-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
80 participants
INTERVENTIONAL
2024-02-22
2026-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low-Intensity Focused Ultrasound and the Complex Patient
NCT06297200
Focused Ultrasound for the Complex Patient
NCT06453109
Understanding the Effects of Transauricular Vagus Nerve Stimulation on Neural Networks and Autonomic Nervous System
NCT05801809
VNS for Long-COVID-19
NCT05630040
Hypnosis and Direct Autonomic Experience Influence on Chronic Symptoms
NCT04303143
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dPI
LIFU to the dPI
Low-intensity focused ultrasound neuromodulation
ultrasound transducer applying low intensity waveforms to targeted brain regions for neuromodulation.
ACC
LIFU to the ACC
Low-intensity focused ultrasound neuromodulation
ultrasound transducer applying low intensity waveforms to targeted brain regions for neuromodulation.
Sham
Sham LIFU application
Sham Low-intensity focused ultrasound
sham application of ultrasound using blocking of the ultrasound waves of the transducer.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low-intensity focused ultrasound neuromodulation
ultrasound transducer applying low intensity waveforms to targeted brain regions for neuromodulation.
Sham Low-intensity focused ultrasound
sham application of ultrasound using blocking of the ultrasound waves of the transducer.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Contraindications to MRI: including pacemaker, aneurysm clips, neurostimulators, cochlear implants, metal in eyes, steel worker, or other implants.
* Contraindications to CT: pregnancy
* Active medical disorder or treatment with potential central nervous system (CNS) effects (e.g. Alzheimer's) -
* History of neurologic disorder. (e.g. Parkinson's, Epilepsy, or Essential Tremor)
* History of head injury resulting in loss of consciousness for \>10 minutes.
* History of alcohol or drug dependence (through self-report).
* History of cardiac disease
* A current or prior use of any cardiac medication (e.g. beta blockers or other anti-arrhythmics)
* A history of diabetes mellitus or use of diabetic medications (e.g. metformin).
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Virginia Polytechnic Institute and State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wynn Legon
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fralin Biomedical Research Institute at VTC
Roanoke, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-049
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.